Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.

Nephrology (Carlton)

Department of Medicine, Dubrava University Hospital, Zagreb Medical School, Zagreb, Croatia.

Published: February 2006

AI Article Synopsis

Article Abstract

The association of interferon (IFN) therapy with haemolytic uraemic syndrome in patients with chronic myeloid leukaemia (CML) has been reported infrequently. The pathogenesis of the renal lesion in such cases remains unclear. We report the case of a patient with chronic myeloid leukaemia who developed nephrotic syndrome and renal failure while being treated with hydroxyurea and IFN-alpha. Renal biopsy showed features of chronic thrombotic microangiopathy. The discontinuation of IFN-alpha, and a prompt institution of plasmapheresis and steroids resulted in improvement of the nephrotic syndrome and renal function. These findings suggest that long-term IFN-alpha therapy can induce thrombotic microangiopathy and haemolytic uraemic syndrome in patients with chronic myeloid leukaemia.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1797.2006.00524.xDOI Listing

Publication Analysis

Top Keywords

chronic myeloid
16
myeloid leukaemia
16
thrombotic microangiopathy
12
haemolytic uraemic
8
uraemic syndrome
8
syndrome patients
8
patients chronic
8
nephrotic syndrome
8
syndrome renal
8
chronic
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!